These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36412252)

  • 41. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
    Tylicki L; Rutkowski P; Renke M; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
    Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renin-angiotensin system may trigger kidney damage in NOD mice.
    Colucci JA; Yuri Arita D; Sousa Cunha T; Seno Di Marco G; Vio CP; Pacheco-Silva A; Casarini DE
    J Renin Angiotensin Aldosterone Syst; 2011 Mar; 12(1):15-22. PubMed ID: 20627940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating renin-angiotensin-aldosterone system activity in cats with systemic hypertension or cardiomyopathy.
    Ward JL; Guillot E; Domenig O; Ware WA; Yuan L; Mochel JP
    J Vet Intern Med; 2022 May; 36(3):897-909. PubMed ID: 35285549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
    Fagyas M; Úri K; Siket IM; Daragó A; Boczán J; Bányai E; Édes I; Papp Z; Tóth A
    PLoS One; 2014; 9(4):e87843. PubMed ID: 24691160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sini decoction alleviates E. coli induced acute lung injury in mice via equilibrating ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis.
    Liu J; Chen Q; Liu S; Yang X; Zhang Y; Huang F
    Life Sci; 2018 Sep; 208():139-148. PubMed ID: 29990483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
    Humalda JK; Lambers Heerspink HJ; Kwakernaak AJ; Slagman MC; Waanders F; Vervloet MG; Ter Wee PM; Navis G; de Borst MH;
    Am J Kidney Dis; 2015 Feb; 65(2):259-66. PubMed ID: 25278093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Limitations of angiotensin inhibition.
    Nobakht N; Kamgar M; Rastogi A; Schrier RW
    Nat Rev Nephrol; 2011 Jun; 7(6):356-9. PubMed ID: 21502972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is hypertension in African-descent populations contributed to by an imbalance in the activities of the ACE2/Ang-(1-7)/Mas and the ACE/Ang II/AT
    Cohall D; Ojeh N; Ferrario CM; Adams OP; Nunez-Smith M
    J Renin Angiotensin Aldosterone Syst; 2020; 21(1):1470320320908186. PubMed ID: 32089050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of ACE inhibitors on cardiac angiotensin II and aldosterone in humans: "Relevance of lipophilicity and affinity for ACE".
    Ruzicka M; Coletta E; White R; Davies R; Haddad H; Leenen FH
    Am J Hypertens; 2010 Nov; 23(11):1179-82. PubMed ID: 20634797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Activity of renin-angiotensin-aldosterone system (RAAS) and vasopressin level in patients with primary pulmonary hypertension].
    Martyniuk TV; Chazova IE; Masenko VP; Volkov VN; Belenkov IuN
    Ter Arkh; 1998; 70(4):33-6. PubMed ID: 9612899
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hospitalized Patients With COVID-19 Have Higher Plasma Aldosterone-Renin Ratio and Lower ACE Activity Than Controls.
    Parikh NI; Arowolo F; Durstenfeld MS; Nah G; Njoroge J; Vittinghoff E; Long CS; Ganz P; Pearce D; Hsue P; Wu AHS; Hajizadeh N; Liu KD; Lynch KL
    J Endocr Soc; 2022 Oct; 6(12):bvac144. PubMed ID: 36338506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renin-angiotensin-aldosterone system polymorphisms and 5-year mortality in survivors of acute myocardial infarction: a report from the Osaka Acute Coronary Insufficiency Study.
    Hara M; Sakata Y; Nakatani D; Suna S; Usami M; Matsumoto S; Sugitani T; Ozaki K; Nishino M; Sato H; Kitamura T; Nanto S; Hamasaki T; Tanaka T; Hori M; Komuro I;
    Int Heart J; 2014; 55(3):190-6. PubMed ID: 24806378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renin angiotensin aldosterone system and ACE I/D gene polymorphism in high-altitude pulmonary edema.
    Kumar R; Pasha Q; Khan AP; Gupta V
    Aviat Space Environ Med; 2004 Nov; 75(11):981-3. PubMed ID: 15558999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.
    Hisatake S; Kiuchi S; Kabuki T; Oka T; Dobashi S; Ikeda T
    Heart Vessels; 2017 Mar; 32(3):303-308. PubMed ID: 27421979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of sample delivery conditions on Renin-Angiotensin-Aldosterone System (RAAS) assay.
    Fu Y; Ge S; Qiu X; Cui R; Zhang C; Xu X; Li J; Feng J; Bai J; Sun M; Liu W
    Scand J Clin Lab Invest; 2020 Jul; 80(4):336-342. PubMed ID: 32189531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of all-trans retinoic acid treatment with the renin-angiotensin aldosterone system expression in glomerulosclerosis rats.
    Zhou TB; Wu WF; Qin YH; Yin SS
    J Renin Angiotensin Aldosterone Syst; 2013 Dec; 14(4):299-307. PubMed ID: 23144044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BML-111, a lipoxin receptor agonist, protects against acute injury via regulating the renin angiotensin-aldosterone system.
    Chen QF; Hao H; Kuang XD; Hu QD; Huang YH; Zhou XY
    Prostaglandins Other Lipid Mediat; 2019 Feb; 140():9-17. PubMed ID: 30412790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sacubitril/valsartan (LCZ696) significantly reduces aldosterone and increases cGMP circulating levels in a canine model of RAAS activation.
    Mochel JP; Teng CH; Peyrou M; Giraudel J; Danhof M; Rigel DF
    Eur J Pharm Sci; 2019 Feb; 128():103-111. PubMed ID: 30508581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension].
    Khadartsev AA; Logatkina AV; Terekhov IV; Bondar SS; Bondar NV
    Ter Arkh; 2017; 89(12):97-102. PubMed ID: 29411767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Etiopathophysiological role of the renin-angiotensin-aldosterone system in age-related muscular weakening: RAAS-independent beneficial role of ACE2 in muscle weakness.
    Fuloria S; Subramaniyan V; Meenakshi DU; Sekar M; Chakravarthi S; Kumar DH; Kumari U; Vanteddu VG; Patel TD; Narra K; Sharma PK; Fuloria NK
    J Biochem Mol Toxicol; 2022 Jun; 36(6):e23030. PubMed ID: 35253303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.